Sebastien Roux

Sebastien Roux is a seasoned professional in the pharmaceutical industry with extensive experience in clinical science and therapeutic specialty representation. Currently serving as a Senior Therapeutic Specialty Representative at Idorsia Pharmaceuticals Ltd since June 2017, Sebastien has previously held significant roles at Actelion, including Head of Clinical Science Early Projects, where leadership was demonstrated in the Endothelin Antagonist program and the bosentan program, which achieved a global NDA for pulmonary arterial hypertension. Prior to Actelion, Sebastien was Preclinical Area Head at Roche, managing preclinical pharmacology across multiple therapeutic areas. Educationally, Sebastien Roux holds a Doctor of Medicine (MD) degree from Medical School Paris and underwent an Interventional Cardiology Residency Program at Université de Montréal.